Skip to main content

Month: September 2023

Lincoln Electric Schedules Webcast For Third Quarter 2023 Results

CLEVELAND, Sept. 28, 2023 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (the “Company”) (Nasdaq: LECO) announced today that it will release its third quarter 2023 results on Friday, October 27, 2023, prior to market open. An investor conference call and webcast will take place at 10:00 a.m. (ET) later that day. Those interested in participating via webcast in listen-only mode may access the event here or on the Company’s Investor Relations home page at https://ir.lincolnelectric.com. For participants who would like to participate via telephone, please register here to receive the dial-in number along with a unique PIN number that is required to access the call. A replay of the earnings call will be available via webcast on the Company’s website. About Lincoln Electric Lincoln Electric is the world leader in the...

Continue reading

Mercer International Inc. Announces Conference Call for Third Quarter 2023 Results

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Mercer International (NASDAQ: MERC) will release its third quarter results for the period ending September 30, 2023, on Thursday, November 2, 2023, after the close of the market. Juan Carlos Bueno, President and Chief Executive Officer, and Richard Short, Chief Financial Officer and Secretary, will be hosting a conference call on Friday, November 3, 2023, at 10:00 am ET to discuss the results. The conference call will be available to interested parties live over the Internet through a webcast by clicking on or copying and pasting the following link into their web browser: https://edge.media-server.com/mmc/p/qc4iogaa A link to the webcast is also available on the Investor Relations section of the company’s webpage. For those unable to participate in the live webcast, a replay of the webcast...

Continue reading

Nyxoah Announces Partnership with ResMed in Germany

Nyxoah Announces Partnership with ResMed in GermanyCreates a continuum of care in the German obstructive sleep apnea market Mont-Saint-Guibert, Belgium – September 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has entered into a partnership with ResMed Germany to increase OSA awareness and therapy penetration in the German market. Nyxoah and ResMed Germany will establish a continuum of care that will educate and guide OSA patients in the German market from diagnosis through treatment. Together, the companies will work to accelerate patient identification and better support patient set-up on the appropriate...

Continue reading

TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will attend and hold one-on-one investor meetings at the upcoming Jones Trading 2023 Healthcare Summit. Dr. Weisman will also present and hold one-on-one investor meetings at the upcoming Roth MKM 2023 Healthcare Opportunities Conference.Jones Trading 2023 Healthcare Summit – October 9-11, 2023       Format:     One-on-one investor meetings       Date/Time:      Tuesday, October 10, 2023, from 8:00 – 5:00 pm ET       Participant:     Harlan Weisman, M.D., Chief Executive Officer        Location:     Eden...

Continue reading

Fortis Inc. to Hold Teleconference and Webcast on October 27 to Discuss Third Quarter 2023 Results

ST. JOHN’S, Newfoundland and Labrador, Sept. 28, 2023 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) will release its third quarter 2023 financial results on Friday, October 27, 2023. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern) during which David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation’s third quarter financial results. Shareholders, analysts, members of the media and other interested parties are invited to listen to the teleconference via the live webcast on the Corporation’s website, https://www.fortisinc.com/investor-relations/events-and-presentations. Those members of the financial community in North America wishing...

Continue reading

HUMBL Announces Launch of HUMBL Pro+ Subscription Service

San Diego, California, Sept. 28, 2023 (GLOBE NEWSWIRE) — HUMBL, Inc. (OTC: HMBL) HUMBL announced today the launch of its HUMBL Pro+ subscription service. As part of the suite of offerings, HUMBL Pro+ subscribers will receive a variety of benefits to help them move from Web 2 to Web 3 through the use of verified profiles, digital wallets, search, advertising and monetization tools. HUMBL Pro will be offered as a base subscription plan, with the fully featured step-up into the HUMBL Pro+ suite offering the following: HUMBL PRO+Early access to new features Social media post editing User-Customizable Pro page Unlimited AI chat services Discount on ads services Become a featured user Priority customer support Special badges and giveaways Extra Community Builder pointsThe HUMBL Pro+ service will offer introductory pricing of $7.99...

Continue reading

Bear Creek Mining Announces $9.5 Million Bought Deal Financing

Not for distribution to U.S. news wire services or for dissemination in the United States. VANCOUVER, British Columbia, Sept. 28, 2023 (GLOBE NEWSWIRE) — Bear Creek Mining Corporation (TSXV: BCM) (BVL: BCM) (the “Company”) announces today that it has entered into an agreement with BMO Capital Markets (“BMO”), under which BMO has agreed to buy on bought deal basis 27,200,000 Units (the “Units”), at a price of $0.35 per Unit for gross proceeds of $9.5 million (the “Offering”). Each unit will be comprised of one common share of the Company (a “Common Share”) and one common share purchase warrant of the Company (“Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 60 months following the closing date of the Offering at an exercise price of $0.42 per Warrant Share,...

Continue reading

Lithium Americas Announces Details for Completion of Separation

VANCOUVER, British Columbia, Sept. 28, 2023 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) is pleased to announce that the separation of the Company into Lithium Americas (Argentina) Corp. (“Lithium Argentina”) and a new Lithium Americas Corp. (“Lithium Americas (NewCo)”) pursuant to a statutory plan of arrangement (the “Separation”) is expected to be completed on Tuesday, October 3, 2023 (the “Effective Date”). Under the terms of the Separation, holders of Lithium Americas common shares (“Lithium Americas Shares”) will be entitled to receive one Lithium Argentina common share (each, a “Lithium Argentina Share”) and one Lithium Americas (NewCo) common share (each, a “Lithium Americas (NewCo) Share”) for every Lithium Americas Share held immediately before the effective time...

Continue reading

Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update

Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC with MET exon14 skipping mutation expected second half 2023 Approximately $52.6 million in cash, cash equivalents, and investments at June 30, 2023; Cash runway to mid-year 2024 Debuted as a publicly traded targeted oncology company March 30, 2023 Management to host conference call Monday, October 2, 2023 at 8:30 a.m. ET FOSTER CITY, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) —  Apollomics Inc. (Nasdaq: APLM) (the “Company”), a late- stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced its financial results for the six months ended June 30, 2023, and provided a corporate update. “The first half of 2023 was a period of significant...

Continue reading

Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS

New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed and Efficiency for Whole genome sequencing (WGS) applications with the Automated Molecular Biology Workstation SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the commercial release of its BioXp® NGS Library Prep kit for Whole Genome Sequencing on the BioXp 3250 and BioXp 9600 systems. This NGS library prep kit enables on-demand and automated library preparation of up to 96 genomic DNA samples for use in whole genome sequencing applications. This new automation capability expands the suite of NGS Library Preparation solutions on the BioXp platform and is expected to enable researchers to reduce hands-on time and cost, while streamlining...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.